Brent Just Erased Its Diplomatic Discount in 24 Hours
Trump’s “we don’t need a deal” post and Houthi claims near Yanbu flipped a week of de-escalation pricing overnight.
Business
Micron Is Down 42% With a December Report Coming
Revenue nearly quadrupled in fiscal 2026. The stock is priced for a cycle bust that the data don’t yet support.
Anthropic Wanted $2 Trillion. Wall Street Is Offering Half That.
What the valuation reset on the AI lab’s roadshow reveals about how professional investors are actually pricing artificial intelligence.
CRISPR Therapeutics Faces Its Biggest Test Yet: Common Disease
Phase 1b data for CTX310 hit Monday morning at AHA, with the big question: can one IV infusion scale into cardiology?
Vertiv Just Posted 61% Revenue Growth. The Stock Dropped 14% Anyway.
A record Q3 beat and raised full-year guidance could not keep VRT above $200. Here is what the gap between fundamentals and price action tells active traders.
The Dow Rose 3% and Nvidia Fell 3%. That Split Is the Whole Story.
One election result, two completely opposite verdicts: what the market is actually repricing when Seoul loses $144 billion and Europe hits a record on the same day.
Maersk’s Q3 Guidance Raise Sent the Stock Down 11%
With freight rates up 46% and investors still selling, the market is telling you something about where 2027 rates land.
Marriott’s Fee Model Is the Real Test in a Regional Collapse
A 43% Middle East RevPAR drop shows what an asset-light model is built for.
Oil Hits a Six-Month High. The Iran Strike Timing Matters.
U.S. allies are bracing for possible post-election action on Iran. Brent near $118 has airlines under pressure, and energy is the clearest trade in the market right now.
Black Sea Is Deadlier Than Hormuz in 2026. Markets Lag.
War-risk cover can reach 15% of hull value, and grain flows are still tightening.